The global capillary blood collection devices market size was valued at USD 2.53 Billion in 2022 and is anticipated to reach USD 10.27 Billion by 2031, expanding at a CAGR of 16.84% during the forecast period, 2023–2031. The growth of the market is attributed to the rising availability of point-of-care (PoC) diagnostics, increasing prevalence of chronic diseases, and various advantages of the product over its alternatives.
Blood collection from capillaries has been performed for many years. The technique was first used to collect blood from children for genetic testing. Small-volume sampling is widely used for various blood collection applications as it offers easy steps for drawing five or ten µl from a newborn baby.
In adults, capillary blood is obtained by pricking a finger, while it is obtained by pricking a foot in babies and small children. The specimen is then collected with a pipette, mounted on a glass slide or filter paper, or absorbed by a micro sampling device's tip.
Capillary blood is used to measure glucose levels by moving it to a test strip. In general, both patients and laboratory technicians prefer capillary blood collection. The approach is easier to use, less painful, and rarely necessarily requires the use of a "second stick."
Except in a few cases, the results of capillary blood versus plasma are equivalent. In such instances, the results must be compared to data collected using the same procedure.
Capillary Blood Collection Devices Market Trends, Drivers, Restraints, and Opportunities
- Growing geriatric population, increasing food-borne disease prevalence, and rapid urbanization are key factors driving the market growth.
- Rising incidence of chronic disorders such as cancer, cardiovascular diseases (CVDs) and diabetes among a large number of the global population is expected to be a significant factor driving market growth over the forecast period.
- Rapid adoption of several innovative technique for blood collection kits in conjunction with point-of-care diagnostics has become the most common form of testing in remote health settings. This is projected to boost the market growth.
- High risks associated with capillary blood collection devices and capillary blood assortment technologies are major restraining factors that can impede the market growth during the forecast period.
- Certain drawbacks of blood micro-collection and the scope of blood contaminations are expected to pose some major obstacles, which can hamper the demand growth.
Scope of Capillary Blood Collection Devices Market Report
The report on the global capillary blood collection devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Capillary Blood Collection Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Materials (Plastic, Glass, Stainless Steel, Ceramic, and Others), Products (Lancets, Micro-container Tubes, Micro-Hematocrit Tubes, Warming Devices, and Others), Applications (Whole Blood, Plasma/Serum Protein Tests, Comprehensive Metabolic Panel Tests, Liver Panel/Liver Profile/Liver Function Tests, and Dried Blood Spot Tests), End-users (Hospitals & Clinics, Blood Donation Centers, Diagnostic Centers, Home Diagnosis, and Pathology Laboratories)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
B. Braun Melsungen AG; SARSTEDT AG & Co. KG; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company (BD); Cardinal Health; Nipro Europe NV; KABE LABORTECHNIK GmbH; Owen Mumford Ltd.; Terumo Medical Corp.; and Greiner Bio-One International GmbH.
|
Capillary Blood Collection Devices Market Segment Insights
Materials Segment Analysis
Based on materials, the global capillary blood collection devices market is divided into plastic, glass, stainless steel, ceramic, and others. The plastic segment accounted for a large revenue share in the market in 2020 due to its high adoption, ease of usage & disposal, and cost-effective nature.
Plastic has been increasingly popular in the medical device industry over the last few decades. Some of the major factors leading to its increasing use in the healthcare settings are due to certain advantages such as safety, chemical stability, transparency & clarity, flexibility, and durability. The segment is expected to dominate e the market during the forecast period.
The glass segment, however, is also expected to expand significantly during the forecast period due to an increasing number of manufacturers are engaged in the production of glass-based products and devices.
Glass also has a high heat tolerance, making it a better choice for medical device manufacturing than other raw materials. The high acceptance of these products is due to their stability, accuracy, and resistance to antimicrobial growth.
Products Segment Analysis
On the basis of products, the market is segmented into lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and others. The lancet segment is expected to constitute a key share of the market in the coming years owing to their frequent usage in blood draw procedures.
The lancet products are mainly equipped with a small scalpel for puncturing the skin in order to extract a blood sample. The market for lancets has been gradually growing as the prevalence of infectious and chronic diseases are increasing at a rapid pace.
Lancets are usually available in two types: disposable and reusable. In clinics and hospitals where a significant number of patients are screened for acute and chronic illnesses, disposable lancets are often used.
For routine glucose and hemoglobin analysis of diabetic and anemic patients, reusable lancet devices are mainly used in home-care settings. On the other hand, the micro-container tubes segment is anticipated to expand at a rapid growth rate during the forecast period.
These tubes are capillary blood collection tubes designed primarily for capillary blood collection. These tubes come in a range of shapes and sizes including serum isolation, EDTA, heparin, and plasma separation tubes. These additive-coated tubes are color-coded and used according to hematology procedures.
Since capillary blood draws only test tiny volumes of blood, they are usually available in microliters. The most common raw materials used to make micro-container tubes are plastic and glass.
Applications Segment Analysis
Based on applications, the global capillary blood collection devices market is segmented into whole blood tests, plasma/serum protein tests, comprehensive metabolite panel (CMP), liver panel tests, and dried blood spot tests.
The whole blood test segment dominated the market in 2020 and is projected to exhibit a healthy growth rate during the forecast period owing to their high frequency and ability to detect a wide range of diseases. The most commonly performed blood tests are complete blood count tests.
The test is widely adopted to determine blood components including white blood cells (WBCs), red blood cells (RBCs), hematocrit, hemoglobin, and platelet counts. These tests provide enough information for doctors to diagnose anomalies to make an accurate diagnosis and are also used to monitor health conditions such as diabetes and anemia.
The increase in infectious and chronic diseases including cancer, anemia, autoimmune diseases, and diabetes globally has increased demand for hematology testing, especially whole blood tests. However, the dried blood spot tests segment is expected to grow significantly during the forecast period owing to their use in the diagnosis of HIV, hepatitis infections, and other diseases.
End-users Segment Analysis
On the basis of end-users, the market is segmented into hospitals & clinics, blood donation centers, diagnostic centers, home diagnosis, and pathology laboratories.
The hospitals & clinics segment is expected to dominate the market with the largest revenue share in the coming years owing to frequent diagnostic testing and large inflow of patients. The need for blood transfusions in hospitals has risen dramatically as the number of surgical operations such as angioplasty, kidney, and liver transplants has increased tremendously.
The home diagnosis segment, however, is expected to expand significantly during the forecast period owing to the introduction of novel devices that facilitate the easy and effective diagnosis of diabetic and anemic patients.
Regional Analysis
In terms of regions, the global capillary blood collection devices market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
North America accounted for a large market share in 2020 and is anticipated to register a high CAGR during the forecast period owing to well-developed healthcare infrastructure and the presence of leading clinical diagnostics companies.
The increased emphasis on clinical research and the rising introduction of emerging technology in this region is likely to propel the regional market growth. A rise in surgical procedures, increase in the number of accidents and emergency cases, and increase in the incidence of noncommunicable and infectious diseases are expected to fuel the regional market growth.
Europe is expected to hold a key share of the market during the forecast period. In the region, the healthcare system is publicly financed, and some countries have adopted universal health care systems. The regional market has been propelled by an expanding base of patients suffering from noncommunicable diseases and the involvement of key market players.
Segments
The global capillary blood collection devices market has been segmented on the basis of
Materials
- Plastic
- Glass
- Stainless Steel
- Ceramic
- Others
Products
- Lancets
- Micro-container Tubes
- Micro-Hematocrit Tubes
- Warming Devices
- Others
Applications
- Whole Blood
- Plasma/Serum Protein Tests
- Comprehensive Metabolic Panel (CMP) Tests
- Liver Panel/Liver Profile/Liver Function Tests
- Dried Blood Spot Tests
End-users
- Hospitals & Clinics
- Blood Donation Centers
- Diagnostic Centers
- Home Diagnosis
- Pathology Laboratories
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Some of the major companies competing in the market are B. Braun Melsungen AG; SARSTEDT AG & Co. KG; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company (BD); Cardinal Health; Nipro Europe NV; KABE LABORTECHNIK GmbH; Owen Mumford Ltd.; Terumo Medical Corp.; and Greiner Bio-One International GmbH.
In terms of distribution networks and operating facilities, some of the major players have a large regional reach. BD, for example, has a presence in over 190 countries.
Key players' failure to develop new products is expected to impede market growth. Other market players have a smaller number of products, which means that key end-users including hospitals and clinics would have fewer options.
In addition, key players are pursuing mergers, acquisitions, and strategic alliances in order to remain competitive in the global arena. Greiner Bio-One, for example, announced the acquisition of Vacuette Espaa and Vacuette Portugal in 2017.
Request For Customization
Enquiry Before Buying
Speak With Analyst
